OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 02, 2009
Contract manufacturers deploy a business model using operations in the US and Western Europe with facilities in Asia.
With the economy down and multinational firms capitalizing on patents in developing countries, India's R&D sector still has a long way to grow.
March 01, 2009
After a year of increased attention on the pharmaceutical supply chain in Asia, what will be the region?s short? and long?term role?
Michiel Ultee talks about the challenges involved in transferring technology to a CMO and why communication is so important.
The productivity of the pharma industry has been declining for several years. Could biotechnology reinvigorate drug development?
February 26, 2009
Also, GPC Biotech AG and Agennix to merge; BASi appoints COO of scientific services; more...
February 19, 2009
Also, Sandoz received approval for its third biosimilar from the EU, WuXi PharmaTech's CFO Benson Tsang to leave at month's end; more...
February 12, 2009
Congressman John D. Dingell (D-MI) introduced HR 759, known as the Food and Drug Globalization Act of 2009, which would amend the Food, Drug, and Cosmetic Act to address food, drug, and device safety, including registration of producers of drugs and applicable fees, documentation for admissibility of drug imports, country of origin labeling, and the inspection of producers of drugs and active pharmaceutical ingredients (API).
Also, PPD to acquire AbC.R.O.; Bilcare Global Clinical Supplies named Tony Moult general manager of Bilcare GCS Europe; more...
February 05, 2009
GS1 UK, an independent organization that develops supply-chain standards, successfully completed the Pharma Traceability Pilot program and demonstrated the viability of a complete track-and-trace system for pharmaceutical products in a live, international supply-chain environment.